| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | 390.8 | 365.6 |
| Gross profit | 30.9 | 28.8 |
| Profit before tax | 7.8 | 11.0 |
| Net income | 2.6 | 10.1 |
| EPS (diluted, $ a share) | $0.11 | $0.40 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -73.8% |
|---|---|
| Revenue, year on year | +6.9% |
| Gross margin | 7.9% |
| Operating margin | 3.2% |
10-Q filed with the SEC, NASDAQ: KE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Kimball Electronics, Inc.: key numbers
- Share price
- $18.86Close, Nov 16
- Market cap
- $452M
- Shares outstanding
- 23.98MLatest SEC cover page
- Sector
- Manufacturing
- Industry
- Printed Circuit BoardsSIC 3672
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Kimball Electronics, Inc.
All →Kimball Electronics Earnings Call: Key Takeaways
Kimball Electronics reported 7% revenue growth driven by medical strength and the Health-Way acquisition, while reiterating FY2027 guidance at the high end despite margin pressure from facility ramps and high tax rates.
Kimball Electronics Financial Results
Kimball Electronics reported Q1 fiscal 2027 net sales of $390.8 million, a 7% year-over-year increase driven by 14% growth in the Medical vertical. The company reiterated its full-year fiscal 2027 guidance, noting that sales are expected to reach the high end of the $1,535 - $1,560 million range.
- Term
- Q1 2027
“I’m encouraged by our first quarter results and solid start to fiscal 2027. Sales increased both sequentially and year-over-year, margins were healthy, and cash conversion days were once again at a multiyear low. The top line benefited from organic sales growth and the contribution from Helvoet Polymer Technologies, our recent tuck-in acquisition in the medical CDMO.”
Richard D. Phillips, Chief Executive Officer